DR3 and its ligand TL1A have been implicated in the pathogenesis of numerous inflammatory conditions associated with secondary osteoporosis including: IBD and rheumatoid arthritis (RA) [13–15]. This evidence concerns the gene TNFSF15 and rheumatoid arthritis.